AI-generated summary
The authors reviewed the literature on photobiomodulation therapy for acute radiodermatitis, a skin reaction caused by radiotherapy. Nine clinical trials were identified, and the authors report that the therapy could significantly reduce the severity of this skin reaction along with discomfort and pain in patients with cancer. They conclude that it might be an effective option, but state that more research is needed to confirm this.
- Studies included
- 9
- Who or what was studied
- Patients with cancer receiving radiotherapy who developed acute radiodermatitis
- Limits stated in the abstract
- The abstract describes a narrative review, does not report pooled sample sizes or certainty of evidence, and the authors themselves say more research is needed to confirm the finding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Low-level laser therapy, Case report, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.